Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-25-063957
Filing Date
2025-06-30
Accepted
2025-06-30 12:08:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 62024
  Complete submission text file 0001104659-25-063957.txt   63830
Mailing Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107
Business Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107 847-986-4190
ACTUATE THERAPEUTICS, INC. (Subject) CIK: 0001652935 (see all company filings)

EIN.: 473044785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-94595 | Film No.: 251090143
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1401 FOCH STREET SUITE 140 FORT WORTH TX 76107
Business Address 1401 FOCH STREET SUITE 140 FORT WORTH TX 76107 817-984-5964
BIOS Fund I, LP (Filed by) CIK: 0001697316 (see all company filings)

EIN.: 815006136 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SCHEDULE 13D/A